LAGOS, Nigeria, June 11, 2026 /PRNewswire/ -- BtcDana has announced a community support initiative in Pakistan and Nigeria following its Eid al-Adha Trading Rewards Campaign, reinforcing the brand's growing commitment to corporate social responsibility (CSR) and local community engagement.

BEIJING, May 26, 2026 /PRNewswire/ -- CGTN published an article during Pakistani Prime Minister Shehbaz Sharif's official visit to China, highlighting how China and Pakistan are working together to bring tangible benefits to both peoples and uphold regional peace and stability amid a turbulent global landscape.

BEIJING, May 26, 2026 /PRNewswire/ -- CGTN published an article during Pakistani Prime Minister Shehbaz Sharif's official visit to China, highlighting how China and Pakistan are working together to bring tangible benefits to both peoples and uphold regional peace and stability amid a turbulent global landscape.

BEIJING, May 26, 2026 /CNW/ -- CGTN published an article during Pakistani Prime Minister Shehbaz Sharif's official visit to China, highlighting how China and Pakistan are working together to bring tangible benefits to both peoples and uphold regional peace and stability amid a turbulent global landscape.

SHANGHAI, May 25, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer.

SHANGHAI, May 24, 2026 /CNW/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer.

SHANGHAI, May 24, 2026 /PRNewswire/ -- A 36-year-old Pakistani patient has achieved encouraging early recovery after receiving personalized CAR-T immunotherapy at Jiahui International Cancer Center in Shanghai, following exhausting standard treatments for aggressive recurrent blood cancer.